FOXO1 and breast carcinoma: The promoter region of multidrug resistance-associated protein 2 (MRP2) contains four FOXO-binding loci, and overexpression of MRP2 in tamoxifen-resistant breast cancer cells is closely associated with FOXO1 (64).